---
title: "BioStock: Elicera Therapeutics receives partial payment of 0,5 MEur from EIC"
date: "2025-02-12 19:08:05"
summary: "Elicera TherapeuticsCell and gene therapy company Elicera Therapeutics has received a partial payment of EUR 500,000 from the European Innovation Council (EIC) under its accelerator program. This is the third of four payments within a funding program that will support the continued clinical development of ELC-301 in the phase I/IIa..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Elicera Therapeutics

Cell and gene therapy company Elicera Therapeutics has received a partial payment of EUR 500,000 from the European Innovation Council (EIC) under its accelerator program. This is the third of four payments within a funding program that will support the continued clinical development of ELC-301 in the phase I/IIa CARMA study.

Read the interview at **biostock.se**:

Elicera Therapeutics receives partial payment of 0,5 MEur from EIC - BioStock

This is a press release from **BioStock - Connecting Innovation & Capital**. https://www.biostock.se

https://news.cision.com/elicera-therapeutics/r/biostock-elicera-therapeutics-receives-partial-payment-of-0-5-meur-from-eic%2Cc4104398

[Reuters](https://www.tradingview.com/news/reuters.com,2025-02-12:newsml_Wkr4kMrKd:0-biostock-elicera-therapeutics-receives-partial-payment-of-0-5-meur-from-eic/)
